Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

43.55
Delayed Data
As of Aug 26
 -0.19 / -0.43%
Today’s Change
36.71
Today|||52-Week Range
45.58
+9.47%
Year-to-Date
3 High-Yield Dividend Stocks to Buy in September
Aug 27 / MotleyFool.com - Paid Partner Content
3 High-Yielding Healthcare Stocks I'm Not Buying
Aug 20 / MotleyFool.com - Paid Partner Content
Can Novartis Tide Over the Alcon Crisis?
Aug 26 / GuruFocus News - Paid Partner Content
Teva Cinqaero Gets EU Nod for Severe Eosinophilic Asthma
Aug 19 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: GlaxoSmithKline, Blackstone Group, Mylan, Lululemo...
Aug 26 / Zacks.com - Paid Partner Content
Glaxo/Pfizer ViiV Healthcare Starts HIV Drug Combo Study
Aug 17 / Zacks.com - Paid Partner Content
Top Research Reports for August 25, 2016
Aug 25 / Zacks.com - Paid Partner Content
Inovio Expands Enrollment in Ebola Vaccine Phase I Study
Aug 15 / Zacks.com - Paid Partner Content
Henderson Revises Global Dividend Expectations Lower For 2016
Aug 22 / TheStreet.com - Paid Partner Content
Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow
Aug 14 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close43.74
Today’s open43.79
Day’s range43.43 - 44.19
Volume3,571,015
Average volume (3 months)3,235,804
Market cap$106.1B
Dividend yield5.06%
Data as of 4:01pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+14.25%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)-3.66%
P/E ratioNM
Price/Sales2.70
Price/Book13.98

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-0.11-0.17%
SNYSanofi+0.34+0.88%
BMYBristol-Myers Squibb+0.01+0.02%
AGNAllergan+1.62+0.69%
Data as of 4:01pm ET, 08/26/2016

Financials

Next reporting dateOctober 26, 2016
EPS forecast (this quarter)$0.76
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers

Search for Jobs